文献速递鼻科

18β-甘草次酸钠抑制变应性鼻炎大鼠鼻黏膜TSLP表达

[The inhibition of 18β-sodium glycyrrhetinic acid on thymic stromal lymphopoietin expression in the nasal mucosa of allergic rhinitis rats].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2019-01-01

该研究将100只Wistar大鼠随机分为对照组、AR模型组、布地奈德组及18β-甘草次酸钠20 mg/kg和40 mg/kg组,每组20只,以OVA致敏建立AR模型并干预2周和4周。结果显示18β-甘草次酸钠可抑制AR大鼠鼻黏膜TSLP及TSLP-mRNA表达,并降低血清IL-4和OVA-sIgE浓度,提示可控制Th2型免疫炎性反应。

要点

  • 18β-甘草次酸钠可抑制AR大鼠鼻黏膜TSLP蛋白及mRNA表达
  • TSLP受抑制伴随血清IL-4和OVA-sIgE浓度下降
  • 该作用提示可控制AR的Th2型免疫炎性反应

核心结论

  • 18β-甘草次酸钠对AR大鼠鼻黏膜TSLP有明显抑制作用,可控制Th2型免疫炎性反应。

研究设计与样本

  • 100只Wistar大鼠雌雄各半,随机分为5组,每组20只:对照组、AR模型组、布地奈德组、18β-甘草次酸钠20 mg/kg组和40 mg/kg组。
  • 除对照组外其他4组以卵清蛋白致敏建立AR动物模型,造模成功后分别给予布地奈德或18β-甘草次酸钠干预,检测时间点为用药2周和4周。
  • 采用免疫组化检测TSLP在鼻黏膜的分布,免疫印迹检测TSLP蛋白表达,RT-PCR检测TSLP-mRNA表达,ELISA检测血清IL-4和OVA-sIgE浓度。

主要发现

  • 免疫组化证实TSLP表达于大鼠鼻黏膜上皮细胞、内皮细胞和上皮纤毛处。
  • AR模型组鼻黏膜TSLP及TSLP-mRNA表达均明显高于对照组(2周TSLP:1.795 9±0.131 4比0.990 5±0.164 2;4周TSLP:1.809 7±0.253 4比0.870 3±0.124 4;2周TSLP-mRNA:4.582 9±0.697 7比1.108 7±0.081 1;4周TSLP-mRNA:4.814 4±0.662 8比1.001 0±0.155 3;P值均<0.05)。
  • 药物干预2周和4周后,布地奈德组、18β-甘草次酸钠20 mg/kg和40 mg/kg组鼻黏膜TSLP及TSLP-mRNA表达均较AR模型组明显受抑制(P值均<0.05),且较对照组差异均无统计学意义。
  • 随着TSLP受抑制,大鼠血清IL-4和OVA-sIgE浓度也降低。

关键数值与推荐

  • TSLP蛋白2周:布地奈德组0.897 8±0.081 8、18β-甘草次酸钠20 mg/kg组1.072 1±0.113 6、40 mg/kg组1.396 6±0.133 9,均低于AR模型组1.795 9±0.131 4(P<0.05)。
  • TSLP蛋白4周:布地奈德组1.191 0±0.161 3、18β-甘草次酸钠20 mg/kg组1.141 0±0.152 3、40 mg/kg组1.200 5±0.189 6,均低于AR模型组1.809 7±0.253 4(P<0.05)。
  • TSLP-mRNA 2周:布地奈德组1.175 6±0.100 9、18β-甘草次酸钠20 mg/kg组1.254 4±0.078 2、40 mg/kg组2.037 2±0.559 2,均低于AR模型组4.582 9±0.697 7(P<0.05)。
  • TSLP-mRNA 4周:布地奈德组1.158 3±0.104 3、18β-甘草次酸钠20 mg/kg组1.224 0±0.034 0、40 mg/kg组1.275 2±0.099 6,均低于AR模型组4.814 4±0.662 8(P<0.05)。

临床怎么用

  • 本研究为动物实验,提示18β-甘草次酸钠可能通过抑制鼻黏膜TSLP及下游Th2相关炎症因子(IL-4、OVA-sIgE)发挥作用。
  • 该结果尚不能直接转化为临床用药推荐,需进一步人体研究验证。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the effect of 18β-sodium glycyrrhetinic acid on thymic stromal lymphopoietin (TSLP) in nasal mucosa of allergic rhinitis (AR) rats. Methods: One hundred Wistar rats,half male and half female,were randomly divided into 5 groups by random number table method: control group, AR model group,budesonide group,18β-sodium glycyrrhetinic acid at dose of 20 mg/kg and 40 mg/kg groups, with 20 rats in each group. AR animal models were established by ovalbumin (OVA) sensitization in the other four experimental groups. After successful modeling, budesonide and 18β-sodium glycyrrhetinic acid were given in each group,and the detection time points were 2 weeks and 4 weeks. The distribution of TSLP in rat nasal mucosa was detected by immunohistochemistry,and the expression of TSLP in rat nasal mucosa was determined by Western blot at the protein level. The expression of TSLP-mRNA in rat nasal mucosa was detected and compared by real-time fluorescence quantitative PCR (RT-PCR) at mRNA level. The concentrations of IL-4 and OVA-sIgE in rat serum were measured and compared by ELISA. One-way analysis of variance and the least significant difference method were used for the comparison among groups, LSD t test was used for the comparison between the two groups,and the difference was statistically significant (P<0.05). Results: Immunohistochemistry confirmed existence of TSLP in rat nasal mucosa, especially in epithelial cells,endothelial cells and epithelial cilia. Western blot and RT-PCR suggested that the expression of TSLP and TSLP-mRNA in nasal mucosa of AR model group was significantly higher than that of control group (2 weeks TSLP: 1.795 9±0.131 4 vs 0.990 5±0.164 2, 4 weeks TSLP: 1.809 7±0.253 4 vs 0.870 3±0.124 4; 2 weeks TSLP-mRNA:4.582 9±0.697 7 vs 1.108 7±0.081 1, 4 weeks TSLP-mRNA:4.814 4±0.662 8 vs 1.001 0±0.155 3; all P<0.05). After 2 weeks and 4 weeks of drug intervention,the expression of TSLP and TSLP-mRNA was inhibited in nasal mucosa of budesonide group,18β-sodium sodium glycyrrhetinic acid at dose of 20 mg/kg and 40 mg/kg group,which was significantly different from that of AR model group (2 weeks TSLP: (0.897 8±0.081 8)/(1.072 1±0.113 6)/(1.396 6±0.133 9) vs 1.795 9±0.131 4; 4 weeks TSLP: (1.191 0±0.161 3)/(1.141 0±0.152 3)/(1.200 5±0.189 6) vs 1.809 7±0.253 4; 2 weeks TSLP-mRNA: (1.175 6±0.100 9)/(1.254 4±0.078 2)/(2.037 2±0.559 2) vs 4.582 9±0.697 7; 4 weeks TSLP-mRNA: (1.158 3±0.104 3)/(1.224 0±0.034 0)/(1.275 2±0.099 6) vs 4.814 4±0.662 8; all P<0.05), and not significantly different from control group. With the inhibition of TSLP, the concentrations of IL-4 and OVA-sIgE in rat serum were also decreased. Conclusion: 18β-sodium glycyrrhetinic acid has obvious inhibitory effect on TSLP in nasal mucosa of AR rats, which can control Th2 type immune inflammatory reaction. 目的: 探索18β-甘草次酸钠对变应性鼻炎(allergic rhinitis,AR)大鼠鼻黏膜胸腺基质淋巴细胞生成素(thymic stromal lymphopoietin,TSLP)的作用。 方法: 100只Wistar大鼠雌雄各半,采用随机数字表法随机分为5组,分别为对照组、AR模型组、布地奈德组、18β-甘草次酸钠20 mg/kg剂量组和40 mg/kg剂量组,每组20只。除对照组外,其他4组以卵清蛋白(ovalbumin,OVA)致敏建立AR动物模型,造模成功后,布地奈德组、18β-甘草次酸钠20 mg/kg剂量组和40 mg/kg剂量组分别给予布地奈德、18β-甘草次酸钠20 mg/kg和40 mg/kg干预,检测时间点为用药2周和4周时。用免疫组织化学(免疫组化)法检测TSLP在大鼠鼻黏膜的分布情况;用免疫印迹法在蛋白水平检测大鼠鼻黏膜TSLP的表达;用实时荧光定量聚合酶链反应(RT-PCR)在基因水平检测大鼠鼻黏膜TSLP-mRNA的表达;用酶联免疫吸附测定法(ELISA)检测大鼠血清中白细胞介素(interleukin,IL)4和OVA特异性IgE(OVA specific IgE,OVA-sIgE)的浓度水平。多组间比较采用单因素方差分析和最小显著差异法,两组间比较采用LSD t检验,P<0.05为差异有统计学意义。 结果: 免疫组化证实大鼠鼻黏膜中TSLP表达于上皮细胞、内皮细胞和上皮纤毛处。免疫印迹和RT-PCR提示AR模型组较对照组大鼠的鼻黏膜TSLP及TSLP-mRNA表达明显增强(2周TSLP:1.795 9±0.131 4比0.990 5±0.164 2,4周TSLP:1.809 7±0.253 4比0.870 3±0.124 4;2周TSLP-mRNA:4.582 9±0.697 7比1.108 7±0.081 1,4周TSLP-mRNA:4.814 4±0.662 8比1.001 0±0.155 3;P值均<0.05)。给予药物干预2周、4周后,与AR模型组相比,布地奈德组、18β-甘草次酸钠20 mg/kg和40 mg/kg剂量组大鼠鼻黏膜TSLP及TSLP-mRNA的表达均被明显抑制[2周TSLP:(0.897 8±0.081 8)/(1.072 1±0.113 6)/(1.396 6±0.133 9)比1.795 9±0.131 4;4周TSLP:(1.191 0±0.161 3)/(1.141 0±0.152 3)/(1.200 5±0.189 6)比1.809 7±0.253 4;2周TSLP-mRNA:(1.175 6±0.100 9)/(1.254 4±0.078 2)/(2.037 2±0.559 2)比4.582 9±0.697 7;4周TSLP-mRNA:(1.158 3±0.104 3)/(1.224 0±0.034 0)/(1.275 2±0.099 6)比4.814 4±0.662 8;P值均<0.05],较对照组差异均无统计学意义。随着TSLP受抑制,血清IL-4、OVA-sIgE浓度也降低。 结论: 18β-甘草次酸钠对AR大鼠鼻黏膜TSLP有明显抑制作用,可以控制Th2型免疫炎性反应。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ji J, Gui Y, Wang YH, et al. [The inhibition of 18β-sodium glycyrrhetinic acid on thymic stromal lymphopoietin expression in the nasal mucosa of allergic rhinitis rats]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31262112. doi:10.3760/cma.j.issn.1673-0860.2019.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。